Frazier Life Sciences Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.6M | Hold |
688,460
| – | – | 3.78% | 7 |
|
|
2025
Q1 | $124M | Sell |
688,460
-100,000
| -13% | -$18M | 5.67% | 6 |
|
|
2024
Q4 | $124M | Sell |
788,460
-200,000
| -20% | -$31.3M | 5.13% | 4 |
|
|
2024
Q3 | $180M | Hold |
988,460
| – | – | 7.21% | 4 |
|
|
2024
Q2 | $182M | Hold |
988,460
| – | – | 8.49% | 3 |
|
|
2024
Q1 | $176M | Hold |
988,460
| – | – | 7.42% | 2 |
|
|
2023
Q4 | $123M | Hold |
988,460
| – | – | 6.56% | 4 |
|
|
2023
Q3 | $115M | Sell |
988,460
-1,800
| -0.2% | -$209K | 7.62% | 3 |
|
|
2023
Q2 | $116M | Buy |
990,260
+44,853
| +5% | +$5.27M | 6.94% | 5 |
|
|
2023
Q1 | $75.7M | Sell |
945,407
-54,330
| -5% | -$4.35M | 5.48% | 7 |
|
|
2022
Q4 | $79.2M | Sell |
999,737
-18,651
| -2% | -$1.48M | 4.92% | 8 |
|
|
2022
Q3 | $71M | Sell |
1,018,388
-77,019
| -7% | -$5.37M | 5.47% | 7 |
|
|
2022
Q2 | $71.9M | Buy |
1,095,407
+229,157
| +26% | +$15M | 6.79% | 3 |
|
|
2022
Q1 | $57.6M | Buy |
+866,250
| New | +$57.6M | 4.91% | 5 |
|